Aligos Therapeutics
ALGS
ALGS
27 hedge funds and large institutions have $14.7M invested in Aligos Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
88% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 24
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$612K | |
| 2 | +$235K | |
| 3 | +$215K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$163K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$94.8K |
Top Sellers
| 1 | -$578K | |
| 2 | -$510K | |
| 3 | -$441K | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$421K |
| 5 |
PBPIA
Pivotal bioVenture Partners Investment Advisor
San Francisco,
California
|
-$260K |